Company Filing History:
1 out of 164 
1 out of 16 Years Active: 2021
Title: Innovations of Andreas Bauman in Radionuclide Complexation
Introduction
Andreas Bauman is a notable inventor based in Schopfheim, Germany. He has made significant contributions to the field of radionuclide complexation, particularly in diagnostics and therapy. His innovative work has implications for both medical imaging and treatment.
Latest Patents
Andreas Bauman holds a patent for "Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy." This invention relates to octadentate ligands represented by the general formula R-D-X-D-X-D-X-D-E-R. In this formula, D can be C(O)N(OH) or N(OH)C(O), pyrimidinone, or pyridinone. Each X is independently a saturated or partially unsaturated, substituted or unsubstituted linker comprising 8-11 atoms selected from N, C, or O. The moiety R can be alkyl, cycloalkyl, arene, or heteroarene, while E is a chain comprising 1-50 atoms. The invention also includes complexes of the ligand, particularly radionuclides, and their applications in radioimmunotherapy and imaging. Bauman has 1 patent to his name.
Career Highlights
Throughout his career, Andreas Bauman has worked at prestigious institutions such as the University of Zurich and University Hospital Basel. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Andreas Bauman has collaborated with notable colleagues, including Malay Patra and Gilles Gasser. Their joint efforts have furthered the development of innovative solutions in the field of radionuclide complexation.
Conclusion
Andreas Bauman's contributions to the field of radionuclide complexation demonstrate his innovative spirit and dedication to advancing medical science. His work continues to influence diagnostics and therapy, showcasing the importance of invention in healthcare.